FDA inspection
IBSA Farmaceutici Italia Srl: FDA inspection ending Jul 14, 2022
FDA inspection 1177870 · No Action Indicated (NAI) · Lodi
Key facts
| Inspection ID | 1177870 |
|---|---|
| Firm | IBSA Farmaceutici Italia Srl |
| FEI number | 3008280916 |
| Address | Via Martiri di Cefalonia 2 |
| City | Lodi |
| Country | Italy |
| Fiscal year | 2022 |
| Inspection end date | Jul 14, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data